He’s not hands on, he’s got tap dance routines to choreograph. Doing presentations / providing guidance and direction / popping balloons at parties / setting high standards is his job, not wearing a lab coat - unless it has sequins for the grand finale.
There’s no point debating what Sir Al said, it’s in the video. They’re aiming for the highest performing test possible and said they believe the minimum is 95/90. He then has a dig at Sona, saying swabs are useless, good ol’ Al. The summary starts at 9:10.
If I’d known we were going to lose you, I’d never have mentioned TILS... starting to move over there, congrats. I was hoping it’d wobble near a quid for a lot longer, but hey ho. Look forward to your cross ramps.... I’m not in the t’other one yet, that’s dribbling down so no loss there
Sam, make your mind up, the share price will go up but the problem is it will tank?
What are your timeframes and how are you defining tank? I can see how currently feels like death by a thousand cuts, but tank is a bit dramatic. Given the information that approvals will in quick measure equal sales and a leap in the price, it’s worth being patient for the rise isn’t it?
Agreed CO, I reckon specificity is in the bag thanks to the joyous wonderment of affimers. For sensitivity, I’ve said before, 80% is useful, 90% very good indeed and 95%+ would be unbelievably incredible. Can’t wait to find out
‘genedrive would not announce contracts or sales etc unless they were actually able to legally deliver product in a country, because of the risk that they would have to retract these statements if for some reason regulatory clearance was not achieved.’
Ergo... they have sales, but are awaiting approvals. Sounds good to me... as you were.
Could someone do me a favour and draw a diagram of who hates who? I’m struggling to keep up with the bickering and who the good guys are. Thanks.
Thanks Timster, but I can’t take credit for Sir Al’s list. Clownfish - expectations of a high performing test are based on the communication from Sir Al in the link provided by Timster. As you’ve seen everything related to Awacta, you’ll already know that.
Timster, please stop posting facts, it’s not big, it’s not clever and it’s not funny.
What is funny is the latest rumour, have you heard that the evil masterminds at Boohoo have trained a bunch of pigeons and that’s going to be our distribution network? What’s worse is they’re only paying them 3.5 teaspoons of seed a day. To make things worse, you should hear about their living conditions. They’re keeping them cooped up.
Probably worth noting that Sona in Canada has tripled just based on initial results from its test strip development. I wouldn’t disagree with your timescale for avct, but I think it’ll bag in the next few weeks as the performance details emerge. They also have a BAMS product on the way, but it won’t have as much of an impact. Also, they’ve had it independently verified that their affimers block the virus, so at any point a major pharma might decide to take a punt on them. I’d shove avct to 2nd on your list currently and by sept way out in front.